Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Trombly Amy Moss
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thornton Bruce
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dal Poggetto John
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DVONCH JEROME J
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Trombly Amy Moss
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dal Poggetto John
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thornton Bruce
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DVONCH JEROME J
Sonoma Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Dal Poggetto John
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Trombly Amy Moss
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Executive Vice President Thornton Bruce
Sonoma Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer DVONCH JEROME J
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
Sonoma Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer White Chad Norman
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
No Data
No Data